GTR Home > Conditions/Phenotypes > 15q13.3 microdeletion syndrome


Excerpted from the GeneReview: 15q13.3 Microdeletion
Individuals with the 15q13.3 microdeletion are at increased risk for a wide range of clinical manifestations including intellectual disability, seizures, autism spectrum disorders, and schizophrenia; however, the microdeletion itself does not appear to lead to a clinically recognizable syndrome and a subset of persons with the deletion have no obvious clinical findings. Behavioral problems are common and mainly comprise poor attention span, hyperactivity, mood disorder, and aggressive and/or impulsive behavior. Intellectual disability, observed in about half of the individuals with this recurrent deletion, is usually mild but can be moderate to severe.

Available tests

10 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Genes See tests for all associated and related genes

  • Also known as: CHRNA7-2, NACHRA7, CHRNA7
    Summary: cholinergic receptor nicotinic alpha 7 subunit

  • Also known as: BTEB3, FKLF2, NSLP1, RFLAT-1, RFLAT1, KLF13
    Summary: Kruppel like factor 13

Clinical features


Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center